Non-surgical care for locally advanced breast cancer: Radiologically assessed therapeutic outcome of a new enzyme-targeting radiosensitization treatment, Kochi oxydol-radiation therapy for unresectable carcinomas, type II (KORTUC II) with systemic chemotherapy

Oncology Reports

Volumn 24, Issue 5, 2010, Pages 1161-1168

  Miyatake, Kana ^a   Kubota, Kei ^a   Ogawa, Yasuhiro ^a   Hamada, Norihiko ^a   Murata, Yoriko ^a   Nishioka, Akihito ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Breast cancer; Computed tomography; Magnetic resonance imaging; Positron emission computed tomography; Radiation therapy; Radiosensitizer; Ultrasonography

Indexed keywords

ANASTROZOLE; CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; EXEMESTANE; FLUORODEOXYGLUCOSE F 18; HYALURONIC ACID; HYDROGEN PEROXIDE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; PACLITAXEL; RADIOSENSITIZING AGENT; TAMOXIFEN; TRASTUZUMAB;

ADULT; ADVANCED CANCER; AGED; ARTICLE; AXILLARY LYMPH NODE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HUMAN; INOPERABLE CANCER; INTRADUCTAL CARCINOMA; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIOSENSITIZATION; UNSPECIFIED SIDE EFFECT;

EID: 78149311437     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000968     Document Type: Article

References (41)

1. UICC: TNM Classification of Malignant Tumors. 6th edition. Wiley-Liss, New York, 2002.
2. Rouzier R, Extra JM, Carton M, et al: Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery. J Clin Oncol 19: 3828-3835, 2001. (Pubitemid 32880061)
3. Lerouge D, Touboul E, Lefranc JP, Genestie C, Moureau-Zabotto L and Blondon J: Locally advanced non-inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients. Cancer Radiother 8: 155-167, 2004. (Pubitemid 38813282)
4. Low JA, Berman AW, Steinberg SM, Danforth DN, Lippman ME and Swain SM: Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy. J Clin Oncol 22: 4067-4074, 2004. (Pubitemid 41185175)
5. Perloff M, Lesnick GJ, Korzun A, et al: Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: a Cancer and Leukemia Group B study. J Clin Oncol 6: 261-269, 1988. (Pubitemid 18065929)
6. De Lena M, Varini M, Zucali R, et al: Multimodal treatment for locally advanced breast cancer. Result of chemotherapy-radiotherapy versus chemotherapy-surgery. Cancer Clin Trials 4: 229-236, 1981.
7. Ogawa Y, Takahashi T, Kobayashi T, et al: Mechanism of apoptotic resistance of human osteosarcoma cell line, HS-Os-1, against irradiation. Int J Mol Med 12: 453-458, 2003.
8. Ogawa Y, Takahashi T, Kobayashi T, et al: Apoptotic-resistance of the human osteosarcoma cell line HS-Os-1 to irradiation is converted to apoptotic-susceptibility by hydrogen peroxide: a potent role of hydrogen peroxide as a new radiosensitizer. Int J Mol Med 12: 845-850, 2003.
9. Ogawa Y, Takahashi T, Kobayashi T, et al: Immunocytochemical characteristics of human osteosarcoma cell line HS-Os-1: possible implication in apoptotic resistance against irradiation. Int J Mol Med 14: 397-403, 2004.
10. Ogawa Y, Ue H, Tsuzuki K, et al: New radiosensitization treatment (KORTUC I) using hydrogen peroxide solution-soaked gauze bolus for unresectable and superficially exposed neoplasms. Oncol Rep 19: 1389-1394, 2008.
11. Ogawa Y, Kubota K, Ue H, et al: Phase I study of a new radiosensitizer containing hydrogen peroxide and sodium hyaluronate for topical tumor injection: a new enzyme-targeting radiosensitization treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II). Int J Oncol 34: 609-618, 2009.
12. Sparano JA, Wang M, Martino S, et al: Weekly paclitaxel in the adjuvant treatment of breast cancer. N Engl J Med 358: 1663-1671, 2008.
13. Therasse P, Arbuck SG, Eisenhauer EA, et al: New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92: 205-216, 2000.
14. Hata Y, Ogawa Y, Nishioka A, Inomata T and Yoshida S: Thin section computed tomography in the prone position for detection of axillary lymph node metastases in breast cancer. Oncol Rep 5: 1403-1406, 1998. (Pubitemid 28474084)
15. Heusner TA, Kuemmel S, Hahn S, et al: Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients. Eur J Nucl Med Mol Imaging 36: 1543-1550, 2009.
16. Fisher B, Redmond C and Fisher ER: The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumor biology - an overview of findings. Cancer 46: 1009-1025, 1980. (Pubitemid 10027061)
17. Kaufmann M, Hortobagyi GN, Goldhirsch A, et al: Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update. J Clin Oncol 24: 1940-1949, 2006.
18. Cabanes PA, Salmon RJ, Vilcoq JR, et al: Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet 339: 1245-1248, 1992.
19. Louis-Sylvestre C, Clough K, Asselain B, et al: Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. J Clin Oncol 22: 97-101, 2004.
20. Ogawa Y, Nishioka A, Inomata T, et al: Conservation treatment intensified with an anti-estrogen agent and CAF chemotherapy for stage I and II breast cancer. Oncol Rep 7: 479-484, 2000.
21. Ogawa Y, Nishioka A, Inomata T, et al: Conservation treatment intensified with tamoxifen and CAF chemotherapy without axillary dissection for early breast cancer patients with clinically-negative axillary nodes. Oncol Rep 6: 801-805, 1999.
22. Chasin WD, Gross CC, Wang CC and Miller D: Hydrogen peroxide and irradiation of tumors. Arch Otolaryngol 85: 151-155, 1967.
23. Bianchini G, Salgarello G, Mennini T and Lorini G: Intraarterial infusion of hydrogen peroxide in radiotherapy of malignant tumors. Radiol Med 55: 207-225, 1969.
24. Bonadonna G, Valagussa P, Brambilla C, Ferrari L, Moliterni A, Terenziani M and Zambetti M: Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute. J Clin Oncol 16: 93-100, 1998.
25. Thomas E, Holmes FA, Smith TL, et al: The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable breast cancer: long-term results from a prospective randomized trial. J Clin Oncol 22: 2294-2302, 2004.
26. Joensuu H, Kellokumpu-Lehtinen PL, Bono P, et al: Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer. N Engl J Med 354: 809-820, 2006.
27. Coates AS, Keshaviah A, Thurlimann B, et al: Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. J Clin Oncol 25: 486-492, 2007.
28. Esserman L, Hylton N, George T and Weidner N: Contrast-enhanced magnetic resonance imaging to assess tumor histopathology and angiogenesis in breast carcinoma. Breast J 5: 13-21, 1999.
29. Esserman L, Hylton N, Yassa L, Barclay J, Frankel S and Sickles E: Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol 17: 110-119, 1999.
30. Tsuboi N, Ogawa Y, Inomata T, Yoshida D, Yoshida S, Moriki T and Kumon M: Changes in the findings of dynamic MRI by preoperative CAF chemotherapy for patients with breast cancer of stage II and III: pathologic correlation. Oncol Rep 6: 727-732, 1999.
31. Kubota K, Ogawa Y, Nishioka A, et al: Diagnostic accuracy of mammography, ultrasonography and magnetic resonance imaging in the detection of intraductal spread of breast cancer following neoadjuvant chemotherapy. Oncol Rep 17: 915-918, 2007.
32. Nakamura S, Kenjo H, Nishi T, Kazama T, Doi O and Suzuki K: Efficacy of 3D-MR mammography for breast conserving surgery after neoadjuvant chemotherapy. Breast Cancer 9: 15-19, 2002.
33. Leconte I, Feger C, Galant C, Berliere M, Berg BV, D'Hoore W and Maldague B: Mammography and subsequent whole-breast sonography of non-palpable breast cancers: the importance of radiologic breast density. AJR 180: 1675-1679, 2003.
34. Yang WT, Lam WW, Cheung H, Suen M, King WW and Metreweli C: Sonographic, magnetic resonance imaging, and mammographic assessments of preoperative size of breast cancer. J Ultrasound Med 16: 791-797, 1997.
35. Berg WA, Gutierrez L, NessAiver MS, Carter WB, Bhargavan M, Lewis RS and Ioffe OB: Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 233: 830-849, 2004.
36. Hata T, Takahashi H, Watanabe K, Takahashi M, Taguchi K, Itoh T and Todo S: Magnetic resonance imaging for preoperative evaluation of breast cancer: a comparative study with mammography and ultrasonography. J Am Coll Surg 198: 190-197, 2004.
37. Van Goethem M, Schelfout K, Dijckmans L, et al: MR mammography in the pre-operative staging of breast cancer in patients with dense breast tissue: comparison with mammography and ultrasound. Eur Radiol 14: 809-816, 2004.
38. Gottlober P, Kerscher MJ, Korting HC and Peter RU: Sonographic determination of cutaneous and subcutaneous fibrosis after accidental exposure to ionising radiation in the course of the Chernobyl nuclear power plant accident. Ultrasound Med Biol 23: 9-13, 1997.
39. Adams MJ, Lipshultz SE, Schwartz C, Fajardo LF, Coen V and Constine LS: Radiation-associated cardiovascular disease: manifestations and management. Semin Radiat Oncol 13: 346-356, 2003.
40. Jones JP and Leeman S: Ultrasonic tissue characterization. Acta Electronica 26: 3-31, 1984.
41. Baz E, Madjar H, Reuss C, Vetter M, Hackeloer B and Holz K: The role of enhanced Doppler ultrasound in differentiation of benign vs. malignant scar lesion after breast surgery for malignancy. Ultrasound Obstet Gynecol 15: 377-382, 2000.